HR6682-119

In Committee

Endometriosis CARE Act

119th Congress Introduced Dec 11, 2025

Summary

What This Bill Does

The Endometriosis CARE Act adds a Public Health Service Act section on endometriosis coverage, awareness, research, and education. NIH may conduct or support research, data collection, surveillance, treatment-option work, a cure-focused research agenda, and an internet clearinghouse for patients and professionals, funded at 50 million dollars per year for fiscal years 2026 through 2030. HHS must analyze barriers to treatment access, including transportation, clinician shortages, coverage gaps, and cost sharing, using Medicaid, CHIP, group health plan, and insurance issuer data, with privacy protections and a public report within two years. HHS must also run public education, provider information efforts, and seek a National Academies study of disparities by race, ethnicity, geography, language, sexual orientation, gender identity, disability, and insurance status.

Who Benefits and How

Patients with endometriosis benefit from more research, clearer treatment information, better public education, and analysis of coverage or access barriers. NIH researchers, health care professionals, health systems, nonprofit organizations, consumer groups, institutions of higher education, and the National Academies benefit from research, clearinghouse, education, and study roles.

Who Bears the Burden and How

HHS and NIH staff must manage research, surveillance, public education, provider dissemination, data collection, privacy safeguards, reports, and a National Academies agreement. Group health plans, insurance issuers, state Medicaid programs, and CHIP programs may be required to provide treatment-access data. Federal taxpayers bear the authorized research and education costs.

Key Provisions

  • Authorizes 50 million dollars per year from fiscal years 2026 through 2030 for NIH endometriosis research, surveillance, and an information clearinghouse.
  • Requires HHS to analyze barriers to endometriosis treatment access using Medicaid, CHIP, group health plan, and insurance data.
  • Directs HHS to disseminate public education and provider information on diagnosis, care, patient communication, and treatment options.
  • Requires a National Academies disparities study and public report within 24 months.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Authorizes NIH endometriosis research, HHS treatment-access analysis, public and provider education, and a National Academies disparities study.

Key Policy Areas

Healthcare, Research & Science, Financial Services

Primary Purpose

Authorizes NIH endometriosis research, HHS treatment-access analysis, public and provider education, and a National Academies disparities study.

Policy Domains

Healthcare Research & Science Financial Services

Substantive provisions

Identified Gains
  • patients with endometriosis
  • NIH researchers
  • health care professionals
  • National Academies
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
NIH researchers: ,
National Academies: ,
health care professionals: ,
patients with endometriosis: ,
Identified Costs
  • Department of Health and Human Services staff
  • National Institutes of Health staff
  • group health plans
  • insurance issuers
  • state Medicaid programs
  • CHIP programs
  • federal taxpayers
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
CHIP programs: ,
federal taxpayers: ,
insurance issuers: ,
group health plans: ,
state Medicaid programs: ,
National Institutes of Health staff: ,
Department of Health and Human Services staff: ,

Legislative Progress

In Committee
Introduced Committee Passed
Dec 11, 2025

Ms. Williams of Georgia (for herself, Ms. Underwood, Ms. Adams, …

Dec 11, 2025

Referred to the House Committee on Energy and Commerce.

Dec 11, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare
3 mentions across 2 clauses
+3 positive

health care professionals receiving endometriosis guidance, patients with endometriosis

Research & Science
2 mentions across 2 clauses
+2 positive

National Academies conducting endometriosis disparities study, National Institutes of Health endometriosis researchers

Financial Services
2 mentions across 2 clauses
-2 negative

group health plans providing treatment access data, insurance issuers providing treatment access data

State & Local Government
2 mentions across 2 clauses
-2 negative

CHIP programs reporting endometriosis services, state Medicaid programs reporting endometriosis services

Government
2 mentions across 2 clauses
-2 negative

Department of Health and Human Services program staff, Department of Health and Human Services reporting staff

Taxpayers
1 mention across 1 clause
-1 negative

federal taxpayers funding endometriosis programs

2/4
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Research & Science Financial Services
Actor Mappings
"Director"
→ Director of the National Institutes of Health
"Secretary"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology